<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28691/iv-daratumumab-versus-subcutaneous-daratumumab?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

IV Daratumumab versus Subcutaneous Daratumumab

Name: IV Daratumumab versus Subcutaneous Daratumumab
Uploaded: 2019-07-02T06:48:09
Duration: 1 min 38 s
Description: Saad Usmani, MD, Chief, Plasma Cell Disorders Program, Hematologic Malignancies, Levine Cancer Institute/Atrium Health, UNC Chapel Hill School of Medicine, compares intravenous daratumumab versus subcutaneous daratumumab.

00:01:38

Don

3 years 127 Views

Share Add to Report 0 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28691/iv-daratumumab-versus-subcutaneous-daratumumab?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://oncologytube.com/videoEmbed/28691/iv-daratumumab-versus-subcutaneous-daratumumab?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://oncologytube.com/videoEmbed/28691/iv-daratumumab-versus-subcutaneous-daratumumab?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://oncologytube.com/v/28691?channelName=obr"><img src="https://oncologytubecom.cdn.ypt.me/videos/video_190702184809_8c60/video_190702184809_8c60.jpg?cache=15660528341678829655">IV Daratumumab versus Subcutaneous Daratumumab</a>

Link (BBCode):

[url=https://oncologytube.com/v/28691?channelName=obr][img]https://oncologytubecom.cdn.ypt.me/videos/video_190702184809_8c60/video_190702184809_8c60.jpg?cache=15660528341678829655[/img]IV Daratumumab versus Subcutaneous Daratumumab[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Acute Lymphoblastic Leukemia

Description:

Saad Usmani, MD, Chief, Plasma Cell Disorders Program, Hematologic Malignancies, Levine Cancer Institute/Atrium Health, UNC Chapel Hill School of Medicine, compares intravenous daratumumab versus subcutaneous daratumumab.